Prof. Dr. Ronald J.A. Wanders received his PhD in Biochemistry in 1982. From 1983 – 1988 he was Postdoctoral Fellow with a joint appointment in the Department of Biochemistry and Clinical Chemistry and started his work on the metabolic functions of peroxisomes which led to the discovery of many newly identified peroxisomal diseases and adequate methods for the pre- and postnatal diagnosis of these disorders. In 1989 he also started to work on mitochondrial fatty acid oxidation deficiencies, which has resulted in the identification of new inborn errors of mitochondrial beta-oxidation. Next to his work on peroxisomes and mitochondrial beta-oxidation he also contributed to other inborn errors of metabolism, including Barth syndrome. This wide range of biochemical tests are now regularly requested by clinicians world-wide, and as such has had an important impact on the health of a large number of patients in many countries.
In 1988 he became Associate Professor and holds a full Professorship in Clinical Enzymology of Inborn Errors of Metabolism since 1996. For his work through the years he received a number of awards, including the International Federation for Clinical Chemistry (IFCC) Distinguished Award for Laboratory Medicine and Patient Care (2011); the Komrower Award of the Society of Inborn Errors of Metabolism (SSIEM) (2012), and the Hamdam Award (2012). He has been the Head of the Laboratory Genetic Metabolic Diseases at the Academic Medical Center, University of Amsterdam, in Amsterdam, The Netherlands, since 2003. The work in his laboratory has subsequently been extended by the development of mouse models, leading to the investigation and the translation of laboratory findings to clinical applications and treatment strategies. His H-factor is 80, and he has published over 1000 peer reviewed papers with well over 30 000 citations (Web of Science Report (July 1st 2017)).